关注
Francesco Pasqualetti
Francesco Pasqualetti
Department of Oncology, Oxford University
在 oncology.ox.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
G Lombardi, GL De Salvo, AA Brandes, M Eoli, R Rudà, M Faedi, I Lolli, ...
The Lancet Oncology 20 (1), 110-119, 2019
2982019
Bevacizumab for the treatment of radiation-induced cerebral necrosis: a systematic review of the literature
D Delishaj, S Ursino, F Pasqualetti, A Cristaudo, M Cosottini, MG Fabrini, ...
Journal of clinical medicine research 9 (4), 273, 2017
892017
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)
R Soffietti, E Trevisan, L Bertero, P Cassoni, I Morra, MG Fabrini, ...
Journal of neuro-oncology 116, 533-541, 2014
872014
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
L Triggiani, R Mazzola, SM Magrini, G Ingrosso, P Borghetti, F Trippa, ...
World journal of urology 37, 2631-2637, 2019
842019
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
F Pasqualetti, M Panichi, A Sainato, F Matteucci, L Galli, P Cocuzza, ...
Radiation Oncology 11, 1-8, 2016
772016
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature
D Delishaj, A Rembielak, B Manfredi, S Ursino, F Pasqualetti, C Laliscia, ...
Journal of Contemporary Brachytherapy 8 (6), 533-540, 2016
722016
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and …
C Bianco, E Giovannetti, F Ciardiello, V Mey, S Nannizzi, G Tortora, ...
Clinical cancer research 12 (23), 7099-7107, 2006
702006
Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies
GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti, N Montemurro, P Perrini, ...
Genes 12 (3), 445, 2021
622021
Clinical management of diffuse low-grade gliomas
G Lombardi, V Barresi, A Castellano, E Tabouret, F Pasqualetti, ...
Cancers 12 (10), 3008, 2020
612020
Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients
E Baldini, A Camerini, A Sgambato, T Prochilo, A Capodanno, ...
Anticancer research 26 (6B), 4415-4421, 2006
582006
Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series
D Delishaj, C Laliscia, B Manfredi, S Ursino, F Pasqualetti, E Lombardo, ...
Journal of contemporary brachytherapy 7 (6), 437-444, 2015
552015
Laser capture microdissection and RNA-seq analysis: High sensitivity approaches to explain histopathological heterogeneity in human glioblastoma FFPE archived tissues
P Civita, S Franceschi, P Aretini, V Ortenzi, M Menicagli, F Lessi, ...
Frontiers in oncology 9, 482, 2019
522019
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis
P Perrini, C Gambacciani, A Weiss, F Pasqualetti, D Delishaj, F Paiar, ...
Journal of neuro-oncology 131, 585-591, 2017
502017
Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series
N Montemurro, GN Fanelli, C Scatena, V Ortenzi, F Pasqualetti, ...
Clinical Neurology and Neurosurgery 207, 106735, 2021
482021
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter …
G Lombardi, A Pace, F Pasqualetti, S Rizzato, M Faedi, E Anghileri, ...
Journal of neuro-oncology 125, 359-367, 2015
472015
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)
P Navarria, G Minniti, E Clerici, S Tomatis, V Pinzi, P Ciammella, ...
Journal of neuro-oncology 142, 59-67, 2019
462019
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
S Scoccianti, E Olmetto, V Pinzi, MF Osti, R Di Franco, S Caini, P Anselmo, ...
Neuro-oncology 23 (10), 1750-1764, 2021
402021
Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas
MG Fabrini, F Perrone, L De Franco, F Pasqualetti, S Grespi, R Vannozzi, ...
Strahlentherapie und Onkologie 185 (8), 524, 2009
402009
Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results
D Delishaj, A Barcellini, R D’Amico, S Ursino, F Pasqualetti, IC Fumagalli, ...
Journal of Contemporary Brachytherapy 10 (6), 559-566, 2018
392018
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
F Pietrantonio, G Aprile, L Rimassa, P Franco, S Lonardi, C Cremolini, ...
Radiotherapy and Oncology 117 (2), 315-321, 2015
392015
系统目前无法执行此操作,请稍后再试。
文章 1–20